BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

4096 related articles for article (PubMed ID: 22002720)

  • 1. N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO.
    Jia G; Fu Y; Zhao X; Dai Q; Zheng G; Yang Y; Yi C; Lindahl T; Pan T; Yang YG; He C
    Nat Chem Biol; 2011 Oct; 7(12):885-7. PubMed ID: 22002720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FTO-mediated formation of N6-hydroxymethyladenosine and N6-formyladenosine in mammalian RNA.
    Fu Y; Jia G; Pang X; Wang RN; Wang X; Li CJ; Smemo S; Dai Q; Bailey KA; Nobrega MA; Han KL; Cui Q; He C
    Nat Commun; 2013; 4():1798. PubMed ID: 23653210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. m
    Wang X; Wu R; Liu Y; Zhao Y; Bi Z; Yao Y; Liu Q; Shi H; Wang F; Wang Y
    Autophagy; 2020 Jul; 16(7):1221-1235. PubMed ID: 31451060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA N6-methyladenosine demethylase FTO regulates PD-L1 expression in colon cancer cells.
    Tsuruta N; Tsuchihashi K; Ohmura H; Yamaguchi K; Ito M; Ariyama H; Kusaba H; Akashi K; Baba E
    Biochem Biophys Res Commun; 2020 Sep; 530(1):235-239. PubMed ID: 32828292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential m
    Wei J; Liu F; Lu Z; Fei Q; Ai Y; He PC; Shi H; Cui X; Su R; Klungland A; Jia G; Chen J; He C
    Mol Cell; 2018 Sep; 71(6):973-985.e5. PubMed ID: 30197295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The tumor-suppressive effects of alpha-ketoglutarate-dependent dioxygenase FTO via N6-methyladenosine RNA methylation on bladder cancer patients.
    Yi W; Yu Y; Li Y; Yang J; Gao S; Xu L
    Bioengineered; 2021 Dec; 12(1):5323-5333. PubMed ID: 34499008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N6-methyl-adenosine modification in messenger and long non-coding RNA.
    Pan T
    Trends Biochem Sci; 2013 Apr; 38(4):204-9. PubMed ID: 23337769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FTO, m
    Mauer J; Jaffrey SR
    FEBS Lett; 2018 Jun; 592(12):2012-2022. PubMed ID: 29754392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysregulation of USP18/FTO/PYCR1 signaling network promotes bladder cancer development and progression.
    Song W; Yang K; Luo J; Gao Z; Gao Y
    Aging (Albany NY); 2021 Jan; 13(3):3909-3925. PubMed ID: 33461172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meclofenamic acid selectively inhibits FTO demethylation of m6A over ALKBH5.
    Huang Y; Yan J; Li Q; Li J; Gong S; Zhou H; Gan J; Jiang H; Jia GF; Luo C; Yang CG
    Nucleic Acids Res; 2015 Jan; 43(1):373-84. PubMed ID: 25452335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FTO-dependent demethylation of N6-methyladenosine regulates mRNA splicing and is required for adipogenesis.
    Zhao X; Yang Y; Sun BF; Shi Y; Yang X; Xiao W; Hao YJ; Ping XL; Chen YS; Wang WJ; Jin KX; Wang X; Huang CM; Fu Y; Ge XM; Song SH; Jeong HS; Yanagisawa H; Niu Y; Jia GF; Wu W; Tong WM; Okamoto A; He C; Rendtlew Danielsen JM; Wang XJ; Yang YG
    Cell Res; 2014 Dec; 24(12):1403-19. PubMed ID: 25412662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Specific
    Zhang Y; Li QN; Zhou K; Xu Q; Zhang CY
    Anal Chem; 2020 Oct; 92(20):13936-13944. PubMed ID: 32972135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FTO suppresses glycolysis and growth of papillary thyroid cancer via decreasing stability of APOE mRNA in an N6-methyladenosine-dependent manner.
    Huang J; Sun W; Wang Z; Lv C; Zhang T; Zhang D; Dong W; Shao L; He L; Ji X; Zhang P; Zhang H
    J Exp Clin Cancer Res; 2022 Jan; 41(1):42. PubMed ID: 35090515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fat mass and obesity associated (FTO)-mediated N6-methyladenosine modification of Krüppel-like factor 3 (KLF3) promotes osteosarcoma progression.
    Shan HJ; Gu WX; Duan G; Chen HL
    Bioengineered; 2022 Apr; 13(4):8038-8050. PubMed ID: 35311620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Saikosaponin D exhibits anti-leukemic activity by targeting FTO/m
    Sun K; Du Y; Hou Y; Zhao M; Li J; Du Y; Zhang L; Chen C; Yang H; Yan F; Su R
    Theranostics; 2021; 11(12):5831-5846. PubMed ID: 33897884
    [No Abstract]   [Full Text] [Related]  

  • 16. FTO-Dependent
    Huang H; Wang Y; Kandpal M; Zhao G; Cardenas H; Ji Y; Chaparala A; Tanner EJ; Chen J; Davuluri RV; Matei D
    Cancer Res; 2020 Aug; 80(16):3200-3214. PubMed ID: 32606006
    [No Abstract]   [Full Text] [Related]  

  • 17. The multifaceted functions of the Fat mass and Obesity-associated protein (FTO) in normal and cancer cells.
    Relier S; Rivals E; David A
    RNA Biol; 2022; 19(1):132-142. PubMed ID: 35067178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural insights into FTO's catalytic mechanism for the demethylation of multiple RNA substrates.
    Zhang X; Wei LH; Wang Y; Xiao Y; Liu J; Zhang W; Yan N; Amu G; Tang X; Zhang L; Jia G
    Proc Natl Acad Sci U S A; 2019 Feb; 116(8):2919-2924. PubMed ID: 30718435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversible RNA adenosine methylation in biological regulation.
    Jia G; Fu Y; He C
    Trends Genet; 2013 Feb; 29(2):108-15. PubMed ID: 23218460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NADP modulates RNA m
    Wang L; Song C; Wang N; Li S; Liu Q; Sun Z; Wang K; Yu SC; Yang Q
    Nat Chem Biol; 2020 Dec; 16(12):1394-1402. PubMed ID: 32719557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 205.